ArticleVaccines2020

A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma.

Ryota Tamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.